Investments in Pharmaceuticals Before and After TRIPS

Margaret Kyle and Anita McGahan

No 15468, NBER Working Papers from National Bureau of Economic Research, Inc

Abstract: We examine the relationship between patent protection for pharmaceuticals and investment in development of new drugs. Patent protection has increased around the world as a consequence of the TRIPS Agreement, which specifies minimum levels of intellectual property protection for members of the World Trade Organization. It is generally argued that patents are critical for pharmaceutical research efforts, and so greater patent protection in developing and least-developed countries might result in greater effort by pharmaceutical firms to develop drugs that are especially needed in those countries. Since patents also have the potential to reduce access to treatments through higher prices, it is imperative to assess whether the benefits of increased incentives have materialized in research on diseases that particularly affect the poor. We find that patent protection is associated with increases in research and development (R&D) effort when adopted in high income countries. However, the introduction of patents in developing countries has not been followed by greater investment. Particularly for diseases that primarily affect the poorest countries, our results suggest that alternative mechanisms for inducing R&D may be more appropriate than patents.

JEL-codes: F13 I11 L65 O34 (search for similar items in EconPapers)
Date: 2009-10
New Economics Papers: this item is included in nep-hea, nep-ino, nep-ipr, nep-pr~ and nep-reg
Note: EH ITI PR
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (10)

Published as Margaret K. Kyle & Anita M. McGahan, 2012. "Investments in Pharmaceuticals Before and After TRIPS," The Review of Economics and Statistics, MIT Press, vol. 94(4), pages 1157-1172, November.

Downloads: (external link)
http://www.nber.org/papers/w15468.pdf (application/pdf)

Related works:
Working Paper: Investments in Pharmaceuticals Before and After TRIPS (2011)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberwo:15468

Ordering information: This working paper can be ordered from
http://www.nber.org/papers/w15468

Access Statistics for this paper

More papers in NBER Working Papers from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().